192 related articles for article (PubMed ID: 20029986)
21. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
Weiss D; Stockmann C; Schrödter K; Rudack C
Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
[TBL] [Abstract][Full Text] [Related]
22. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Virani S; Bellile E; Bradford CR; Carey TE; Chepeha DB; Colacino JA; Helman JI; McHugh JB; Peterson LA; Sartor MA; Taylor JM; Walline HM; Wolf GT; Rozek LS
BMC Cancer; 2015 Oct; 15():825. PubMed ID: 26518708
[TBL] [Abstract][Full Text] [Related]
23. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
24. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.
Degli Esposti D; Sklias A; Lima SC; Beghelli-de la Forest Divonne S; Cahais V; Fernandez-Jimenez N; Cros MP; Ecsedi S; Cuenin C; Bouaoun L; Byrnes G; Accardi R; Sudaka A; Giordanengo V; Hernandez-Vargas H; Pinto LF; Van Obberghen-Schilling E; Herceg Z
Genome Med; 2017 Apr; 9(1):33. PubMed ID: 28381277
[TBL] [Abstract][Full Text] [Related]
25. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
26. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
27. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.
de Freitas Cordeiro-Silva M; Stur E; Agostini LP; de Podestá JR; de Oliveira JC; Soares MS; Mendonça EF; Gouvea SA; Von Zeidler SV; Louro ID
Mol Biol Rep; 2012 Dec; 39(12):10111-9. PubMed ID: 22936053
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
Franzen A; Bootz F; Dietrich D
HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation.
Weiss D; Basel T; Sachse F; Braeuninger A; Rudack C
Mol Carcinog; 2011 Sep; 50(9):680-8. PubMed ID: 21563216
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma of the head and neck in the HPV era.
Cardesa A; Nadal A
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Sep; 20(3):161-73. PubMed ID: 22131117
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma.
Marsit CJ; McClean MD; Furniss CS; Kelsey KT
Int J Cancer; 2006 Oct; 119(8):1761-6. PubMed ID: 16708382
[TBL] [Abstract][Full Text] [Related]
33. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
34. Integrated virus-host methylome analysis in head and neck squamous cell carcinoma.
Wilson GA; Lechner M; Köferle A; Caren H; Butcher LM; Feber A; Fenton T; Jay A; Boshoff C; Beck S
Epigenetics; 2013 Sep; 8(9):953-61. PubMed ID: 23867721
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
[TBL] [Abstract][Full Text] [Related]
36. Molecular and IHC analysis of head and neck carcinomas associated with HPV infection.
Stanek L; Glendova K; Tesarova P; Gurlich R; Holeckova P; Musil Z; Hrudka J; Pala M; Mateicka F; Chovanec M
Bratisl Lek Listy; 2019; 120(11):832-838. PubMed ID: 31747763
[TBL] [Abstract][Full Text] [Related]
37. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
[TBL] [Abstract][Full Text] [Related]
38. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
39. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma.
Applebaum KM; McClean MD; Nelson HH; Marsit CJ; Christensen BC; Kelsey KT
Int J Cancer; 2009 Jun; 124(11):2690-6. PubMed ID: 19230024
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
